Risk of tuberculosis disease in patients receiving TNF-α antagonist therapy: A meta-analysis of randomized controlled trials

Risk of tuberculosis disease in patients receiving TNF-α antagonist therapy: A meta-analysis of randomized controlled trials

Introduction: Tuberculosis (TB) risk associated with tumor necrosis factor-alpha (TNF-α) antagonist therapy in patients with autoimmune diseases is a significant concern. This study aims to evaluate the risk of TB disease associated with TNF-α antagonist therapy. Methods: An extensive search of PubM...

Full description

Saved in:
Bibliographic Details
Main Authors: Fatemeh Khelghati, Mohammad Rahmanian, Elaheh Eghbal, Zahra Sadat Seghatoleslami, Mehdi Goudarzi, Aliasghar Keramatinia, Catherine WM. Ong, Delia Goletti, Lia D'Ambrosio, Rosella Centis, Mohammad Javad Nasiri, Giovanni Battista Migliori
Format: Article
Language:English
Published: Elsevier 2024-12-01
Series:New Microbes and New Infections
Subjects:
Tuberculosis
TNF-α antagonist therapy
Autoimmune diseases
Rheumatoid arthritis
Adalimumab
Golimumab
Online Access:http://www.sciencedirect.com/science/article/pii/S2052297524003172
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

http://www.sciencedirect.com/science/article/pii/S2052297524003172

Similar Items